As of Nov 19
| +0.02 / +0.17%|
The 6 analysts offering 12-month price forecasts for Viking Therapeutics Inc have a median target of 29.50, with a high estimate of 43.00 and a low estimate of 22.50. The median estimate represents a +153.00% increase from the last price of 11.66.
The current consensus among 7 polled investment analysts is to Buy stock in Viking Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.